Prevalence and economic burden of pulmonary embolism in Germany

Vascular Medicine (United Kingdom)

Volumn 17, Issue 5, 2012, Pages 303-309

  Kröger, Knut ^a,b   Küpper Nybelen, Jutta ^c   Moerchel, Christian ^b   Moysidis, Theodoros ^a   Kienitz, Carsten ^d   Schubert, Ingrid ^c  

^a HELIOS KLINIKUM KREFELD   (Germany)

^b Thrombose Initiative EV   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

costs; mortality; prevalence; pulmonary embolism

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; CERTOPARIN; ENOXAPARIN; HEPARIN DERIVATIVE; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ADULT; AGED; ARTICLE; COST OF ILLNESS; ECONOMIC ASPECT; FEMALE; GERMANY; HEALTH CARE COST; HEALTH INSURANCE; HOSPITAL COST; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LUNG EMBOLISM; MALE; MORTALITY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SURVIVAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTICOAGULANTS; CROSS-SECTIONAL STUDIES; DRUG COSTS; FEMALE; GERMANY; HEALTH CARE COSTS; HOSPITAL COSTS; HOSPITAL MORTALITY; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; PATIENT DISCHARGE; PREVALENCE; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867383149     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X12449363     Document Type: Article

References (33)

1. Geerts WH, Bergqvist D, Pineo GF, et al. American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2008 ; 133 (6 Suppl). 381S - 453S
2. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA. 1998 ; 279: 458-462
3. Lilienfeld DE. Decreasing mortality from pulmonary embolism in the United States, 1979-1996. Int J Epidemiol. 2000 ; 29: 465-469
4. Piazza G, Goldhaber SZ. Acute pulmonary embolism: Part II: treatment and prophylaxis. Circulation. 2006 ; 114: e42-47
5. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Arch Intern Med. 1998 ; 158: 585-593
6. Lilienfeld DE, Chan E, Ehland J, Godbold JH, Landrigan PJ, Marsh G. Mortality from pulmonary embolism in the United States: 1962 to 1984. Chest. 1990 ; 98: 1067-1072
7. Skaf E, Stein PD, Beemath A, Sanchez J, Olson RE. Fatal pulmonary embolism and stroke. Am J Cardiol. 2006 ; 97: 1776-1777
8. Murray DW, Britton AR, Bulstrode CJ. Thromboprophylaxis and death after total hip replacement. J Bone Joint Surg Br. 1996 ; 78: 863-870
9. Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998: An analysis using multiple-cause mortality data. Arch Intern Med. 2003 ; 163: 1711-1717
10. Stein PD, Kayali F, Olson RE. Estimated case fatality rate of pulmonary embolism, 1979 to 1998. Am J Cardiol. 2004 ; 93: 1197-1199
11. Hoffmann B, Gross CR, Jöckel KH, Kröger K. Trends in mortality of pulmonary embolism-An international comparison. Thromb Res. 2010 ; 125: 303-308
12. Cohen AT, Tapson VF, Bergmann JF, et al. ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): A multinational cross-sectional study. Lancet. 2008 ; 371: 387-394
13. Kröger K, Moerchel Ch, Moysidis T, Santosa F. Incidence rate of pulmonary embolism in Germany: Data from the federal statistical office. J Thromb Thrombolysis. 2010 ; 29: 349-353
14. Ihle P, Köster I, Herholz H, Rambow-Bertram P, Schardt T, Schubert I. Versichertenstichprobe AOK Hessen/KV Hessen-Konzeption und Umsetzung einer personenbezogenen Datenbasis aus der gesetzlichen Krankenversicherung. [Sample survey of persons insured in statutory health insurance institutions in Hessen-Concept and realisation of person-related database]. Gesundheitswesen. 2005 ; 67: 638-645
15. Schubert I, Ihle P, Köster I Routinedaten im Gesundheitswesen. Handbuch Sekundärdatenanalyse: Grundlagen, Methoden, Perspektiven. Swart E Ihle P, ed. Bern: Verlag Hans Huber ; 2005: 235-241.
16. Schubert I, Ihle P, Köster I. [Internal confirmation of diagnoses in routine statutory health insurance data: Concept with examples and case definitions]. Gesundheitswesen. 2010 ; 72: 316-322
17. Köster I, von Ferber L, Ihle P, Schubert I, Hauner H. The cost burden of diabetes mellitus: The evidence from Germany-the CoDiM Study. Diabetologia. 2006 ; 49: 1498-1504
18. Köster I, Huppertz E, Hauner H, Schubert I. Direct costs of diabetes mellitus in Germany, CoDiM 2000-2007. Exp Clin Endocrinol Diabetes. 2010 ; 118: 1-9
19. Lederle FA, Zylla D, MacDonald R, Wilt TJ. Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: A background review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2011 ; 155: 602-615
20. Oger E. Incidence of venous thromboembolism: A community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost. 2000 ; 83: 657-660
21. Park B, Messina L, Dargon P, Huang W, Ciocca R, Anderson FA. Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: Findings from the nationwide inpatient sample. Chest. 2009 ; 136: 983-990
22. Burge AJ, Freeman KD, Klapper PJ, Haramati LB. Increased diagnosis of pulmonary embolism without a corresponding decline in mortality during the CT era. Clin Radiol. 2008 ; 63: 381-386
23. Stein PD, Hull RD, Patel KC, et al. Venous thromboembolic disease: Comparison of the diagnostic process in men and women. Arch Intern Med. 2003 ; 163: 1689-1694
24. Sare GM, Gray LJ, Bath PM. Association between hormone replacement therapy and subsequent arterial and venous vascular events: A meta-analysis. Eur Heart J. 2008 ; 29: 2031-2041
25. Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: Results of a multicenter registry. J Am Coll Cardiol. 1997 ; 30: 1165-1171
26. Guijarro R, Montes J, Sanromán C, Monreal M. Venous thromboembolism in Spain. Comparison between an administrative database and the RIETE registry. Eur J Intern Med. 2008 ; 19: 443-446
27. Nutescu EA, Shorr AF, Farrelly E, Horblyuk R, Happe LE, Franklin M. Burden of deep vein thrombosis in the outpatient setting following major orthopedic surgery. Ann Pharmacother. 2008 ; 42: 1216-1221
28. Spyropoulos AC, Lin J. Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: An administrative claims analysis from 30 managed care organizations. J Manag Care Pharm. 2007 ; 13: 475-486
29. Dobesh PP. Economic burden of venous thromboembolism in hospitalized patients. Pharmacotherapy. 2009 ; 29: 943-953
30. MacDougall DA, Feliu AL, Boccuzzi SJ, Lin J. Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. Am J Health Syst Pharm. 2006 ; 63 (20 Suppl 6). S5-15
31. Stausberg J. Quality of coding in acute inpatient care. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitss-chutz. 2007 ; 50: 1039-1046
32. Hullegie P, Klein TJ. The effect of private health insurance on medical care utilization and self-assessed health in Germany. Health Econ. 2010 ; 19: 1048-1062
33. Spencer FA, Lessard D, Emery C, Reed G, Goldberg RJ. Venous thromboembolism in the outpatient setting. Arch Intern Med. 2007 ; 167: 1471-1475